Implementation of a Weight Management Pharmaceutical Care Service

Annals of Pharmacotherapy

Volumn 41, Issue 2, 2007, Pages 185-192

  Lloyd, Kimberly Braxton ^a,e   Thrower, Margaret Ryman ^b   Walters, Natasha Boutwell ^c   Krueger, Kem P ^d   Stamm, Pamela L ^e   Evans, R Lee ^e  

^a AUBURN UNIVERSITY   (United States)

^b McKesson Medication Management   (United States)

^c Target Pharmacy   (United States)

^d UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

^e AUBURN UNIVERSITY   (United States)

Author keywords

Anorexiants; Anorexics; Obesity; Vitamins; Weight management

Indexed keywords

AMITRIPTYLINE; AMLODIPINE; ATENOLOL; CLOFIBRATE; CORTISONE; DESIPRAMINE; DICLOFENAC; DOXEPIN; GABAPENTIN; HYDROCORTISONE; IBUPROFEN; IMIPRAMINE; INSULIN; ITRACONAZOLE; KETOROLAC; METHYLTESTOSTERONE; NIFEDIPINE; NORTRIPTYLINE; ORAL CONTRACEPTIVE AGENT; PIROXICAM; PREDNISOLONE; PREDNISONE; PROPRANOLOL; SULFONYLUREA DERIVATIVE; TAMOXIFEN; TESTOSTERONE; TRIMIPRAMINE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN;

ADULT; ANKLE EDEMA; ARTICLE; AWARENESS; BEHAVIOR MODIFICATION; BODY FAT; BODY MASS; CARBOHYDRATE DIET; EPIDEMIC; EXERCISE TOLERANCE; FATIGUE; FEMALE; FLUID RETENTION; FRUIT; HIGH FIBER DIET; HUMAN; INCREASED APPETITE; MAJOR CLINICAL STUDY; MALE; METABOLISM; MORBIDITY; MORTALITY; MUSCLE WEAKNESS; OBESITY; PATIENT MONITORING; PERIPHERAL EDEMA; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SIDE EFFECT; SODIUM RETENTION; TREATMENT OUTCOME; UNITED STATES; VEGETABLE; WEIGHT GAIN; WORK CAPACITY; WORKLOAD;

ADULT; ANTI-OBESITY AGENTS; BODY MASS INDEX; BODY WEIGHT; FEMALE; HUMANS; MALE; MONITORING, PHYSIOLOGIC; OBESITY; PATIENT EDUCATION; PHARMACEUTICAL SERVICES; RETROSPECTIVE STUDIES; STUDENT HEALTH SERVICES; TEACHING MATERIALS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 33847399674     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E466     Document Type: Article

References (18)

1. National Center for Chronic Disease Prevention and Health Promotion. Overweight and obesity trends: 1991-2001 prevalence of obesity among US adults by state. www.cdc.gov/nccdphp/dnpa/obesity/trend/prev_reg. htm (accessed 2006 Jul 30).
2. National Center for Chronic Disease Prevention and Health Promotion. Chronic disease prevention fact sheet. Overweight and obesity trends. www.cdc.gov/nccdphp/dnpa/obesity/consequences.htm (accessed 2006 Jul 30).
3. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004;291:1238-45.
4. Campbell ML, Mathys ML. Pharmacologic options for the treatment of obesity. Am J Health Syst Pharm 2001;58:1301-8.
5. Rechtner-Mors M, Ditschuneit HH, Johnson TD, Suchard MA, Adler G. Metabolic and weight loss effects of long-term dietary intervention in obese patients, four-year results. Obes Res 2000;8:399-402.
6. Quesenberry CP, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med 1998;158:466-72.
7. Malone M, Alger-Mayer SA. Pharmacist intervention enhances adherence to orlistat therapy. Ann Pharmacother 2003;37:1598-602. Epub 5 Sept 2003. DOI 10.1345/aph.1D183
8. Ahrens RA, Hower M, Best AM. Effects of weight reduction interventions by community pharmacists. J Am Pharm Assoc 2003;43:583-9.
9. Lloyd KB, Krueger KP, Moore RT, Walters NB, Eichner SF, Fanning K. Impact of a workplace health and wellness pharmaceutical care service on the weight and obesity classification of employees. J Am Pharm Assoc (Wash) 2002;42:118-20.
10. Srnka Q. Weight management and the pharmacist's role: the blueprint provided here on how to establish a weight management program can help pharmacists to break new ground in patient care. US Pharmacist 1999;24:107-16.
11. Baily R. Putting pharmaceutical care into practice: Mike Gemma develops unique niche-helping patients manage weight loss. Commun Pharmacist 1997;(Sept/Oct):24-6.
12. Slezak M. Converting lost pounds into dollars. Am Druggist 1996;(December):213:38-40.
13. Obesity and overweight in Alabama fact sheet. Alabama Center for Health Statistics, April 2003. http://ph.state.al.us/chs/HalthStatistics/Reports/ obesity%20fact%20sheetPDF (accessed 2006 Jul 31).
14. Babb VJ, Babb J. Pharmacist involvement in Healthy People 2010. J Am Pharm Assoc (Wash) 2003;43:56-60.
15. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health 1998;1-262. www.nhlbi.nih.gov/guidelines/obesity/ob_gdIns.pdf (accessed 2006 Jul 31).
16. Dukes MNG, Aronson JK, eds. Meyler's side effects of drugs: an encyclopedia of adverse reactions and interactions. 14th ed. Amsterdam: Elsevier, 2000.
17. MICROMEDEX healthcare series. Vol. 21. Greenwood Village, CO: Thomson MICROMEDEX, expired Sept 2006.
18. Fernstrom MH, Fernstrom JD. The new role of pharmacotherapy for weight reduction in obesity. Int J Clin Pract 2002;56:683-6.